Dave Chase
Few have a more comprehensive view of what the future of healthcare look like based on deep study of the leading organizations wildly out-performing the status quo.
Chase is regularly invited to industry and company-specific events to shift mindsets. These range from board meetings to executive staff strategy sessions to internal innovation events. Chase's pattern recognition helps companies capitalize on the vast opportunities that have emerged as a result of $1 trillion (just in the U.S.) expected to shift from old players/business models to new over the next 10 years. Chase understands the idiosyncrasies of healthcare without being shackled by them.
Chase's talks have led to major strategy shifts and new business initiatives inside of leading health organizations.
Chase is simultaneously incredibly disappointed by the under-performance of the health ecosystem and super optimistic about what is possible when we harness the smarts, passion and determination of the clinicians that underpin our system.
Recent speeches and strategy sessions have been in the following areas:
- Guiding principles for new healthcare products and services in Healthcare's Age of Enlightenment
- Opportunities & threats related to the reinvention of health benefits
- Healthcare as a community economic development differentiator
- How to infuse startup energy & innovation into established companies
- The Future Health Ecosystem Today -- a comprehensive look into the future health ecosystem by looking at high-performing organizations that give a lens into the future
- How Chase spent less than $5000 on marketing with his last company yet had greater industry visibility than companies spending hundreds of times more and how this led to new customers, investors and ultimately an exit.
Private events (publicly reference-able companies listed)
- Life Science & Medical Device companies such as Bayer, Genentech, GSK, J&J, Medtronic, Novartis, Roche, & UCB
- Health systems such as Alina, SSM Healthcare, & St. Luke's
- Health plan related including to divisions of Cambia & Multiplan
- High Growth companies such as Maxwell Health
Conferences: I've spoken before thousands of people at various industry conferences ranging from national conferences such as HIMSS to regional business coalitions and discipline-specific organizations.
Few have a more comprehensive view of what the future of healthcare look like based on deep study of the leading organizations wildly out-performing the status quo.
Chase is regularly invited to industry and company-specific events to shift mindsets. These range from board meetings to executive staff strategy sessions to internal innovation events. Chase's pattern recognition helps companies capitalize on the vast opportunities that have emerged as a result of $1 trillion (just in the U.S.) expected to shift from old players/business models to new over the next 10 years. Chase understands the idiosyncrasies of healthcare without being shackled by them.
Chase's talks have led to major strategy shifts and new business initiatives inside of leading health organizations.
Chase is simultaneously incredibly disappointed by the under-performance of the health ecosystem and super optimistic about what is possible when we harness the smarts, passion and determination of the clinicians that underpin our system.
Recent speeches and strategy sessions have been in the following areas:
- Guiding principles for new healthcare products and services in Healthcare's Age of Enlightenment
- Opportunities & threats related to the reinvention of health benefits
- Healthcare as a community economic development differentiator
- How to infuse startup energy & innovation into established companies
- The Future Health Ecosystem Today -- a comprehensive look into the future health ecosystem by looking at high-performing organizations that give a lens into the future
- How Chase spent less than $5000 on marketing with his last company yet had greater industry visibility than companies spending hundreds of times more and how this led to new customers, investors and ultimately an exit.
Private events (publicly reference-able companies listed)
- Life Science & Medical Device companies such as Bayer, Genentech, GSK, J&J, Medtronic, Novartis, Roche, & UCB
- Health systems such as Alina, SSM Healthcare, & St. Luke's
- Health plan related including to divisions of Cambia & Multiplan
- High Growth companies such as Maxwell Health
Conferences: I've spoken before thousands of people at various industry conferences ranging from national conferences such as HIMSS to regional business coalitions and discipline-specific organizations.
Unleashing the American Dream by Thwarting the Healthcare Heist
